FDA approves weight-loss drug to treat sleep apnea
The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use,
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
The U.S. Food and Drug Administration (FDA) now classifies eggs as a “healthy, nutrient-dense" food, according to a new ...
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
The Food and Drug Administration released new guidelines on what foods can be labeled "healthy." The new guidance now ...
A new rule from the Food and Drug Administration (FDA) will update what it means for food to be labeled “healthy” for the ...
Tis the season to wash your hands and watch what you eat. Norovirus, a vomit- and diarrhea-inducing stomach bug, is sickening ...
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries.
The FDA has issued a slew of recalls in the last three weeks, with many products containing cucumbers and other vegetables ...
Earlier this month, the US Food and Drug Administration (FDA) issued new draft guidance regarding their accelerated approval pathway for new drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback